Comparison of index-linked HIV testing for children and adolescents in health facility and community settings in Zimbabwe: findings from the interventional B-GAP study.


Journal

The lancet. HIV
ISSN: 2352-3018
Titre abrégé: Lancet HIV
Pays: Netherlands
ID NLM: 101645355

Informations de publication

Date de publication:
03 2021
Historique:
received: 31 03 2020
revised: 01 09 2020
accepted: 10 09 2020
pubmed: 17 11 2020
medline: 17 3 2021
entrez: 16 11 2020
Statut: ppublish

Résumé

Index-linked HIV testing, whereby children of individuals with HIV are targeted for testing, increases HIV yield but relies on uptake. Community-based testing might address barriers to testing access. In the Bridging the Gap in HIV testing and care for children in Zimbabwe (B-GAP) study, we investigated the uptake and yield of index-linked testing in children and the uptake of community-based vs facility-based HIV testing in Zimbabwe. B-GAP was an interventional study done in the city of Bulawayo and the province of Matabeleland South between Jan 29 and Dec 12, 2018. All HIV-positive attendees (index patients) at six urban and three rural primary health-care clinics were offered facility-based or community-based HIV testing for children (age 2-18 years) living in their households who had never been tested or had tested as HIV-negative more than 6 months ago. Community-based options involved testing in the home by either a trained lay worker with a blood-based rapid diagnostic test (used in facility-based testing), or by the child's caregiver with an oral HIV test. Among consenting individuals, the primary outcome was testing uptake in terms of the proportion of eligible children tested. Secondary outcomes were uptake of the different HIV testing methods, HIV yield (proportion of eligible children who tested positive), and HIV prevalence (proportion of HIV-positive children among those tested). Logistic regression adjusting for within-index clustering was used to investigate index patient and child characteristics associated with testing uptake, and the uptake of community-based versus facility-based testing. Overall, 2870 index patients were linked with 6062 eligible children (3115 [51·4%] girls [sex unknown in seven], median age 8 years [IQR 5-13]). Testing was accepted by index patients for 5326 (87·9%) children, and 3638 were tested with a known test outcome, giving an overall testing uptake among 6062 eligible children of 60·0%. 39 children tested positive for HIV, giving an HIV prevalence among the 3638 children of 1·1% and an HIV yield among 6062 eligible children of 0·6%. Uptake was positively associated with female sex in the index patient (adjusted odds ratio [aOR] 1·56 [95% CI 1·38-1·77], p<0·0001) and child (aOR 1·10 [1·03-1·19], p=0·0080), and negatively associated with any financial cost of travel to a clinic (aOR 0·86 [0·83-0·88], p<0·0001), increased child age (6-9 years: aOR 0·99 (0·89-1·09); 10-15 years: aOR 0·91 [0·83-1·00]; and 16-18 years: aOR 0·75 [0·66-0·85]; p=0·0001 vs 2-5 years), and unknown HIV status of the mother (aOR 0·81 [0·68-0·98], p=0·027 vs HIV-positive status). Additionally, children had increased odds of being tested if community-based testing was chosen over facility-based testing at screening (1320 [73·9%] children tested of 1787 vs 2318 [65·5%] of 3539; aOR 1·49 [1·22-1·81], p=0·0001). The HIV yield of index-linked testing was low compared with blanket testing approaches in similar settings. Index-linked HIV testing can improve testing uptake among children, although strategies that improve testing uptake in older children are needed. Community based testing by lay workers is a feasible strategy that can be used to improve uptake of HTS among children and adolescents. UK Medical Research Council, UK Department for International Development, Wellcome Trust.

Sections du résumé

BACKGROUND
Index-linked HIV testing, whereby children of individuals with HIV are targeted for testing, increases HIV yield but relies on uptake. Community-based testing might address barriers to testing access. In the Bridging the Gap in HIV testing and care for children in Zimbabwe (B-GAP) study, we investigated the uptake and yield of index-linked testing in children and the uptake of community-based vs facility-based HIV testing in Zimbabwe.
METHODS
B-GAP was an interventional study done in the city of Bulawayo and the province of Matabeleland South between Jan 29 and Dec 12, 2018. All HIV-positive attendees (index patients) at six urban and three rural primary health-care clinics were offered facility-based or community-based HIV testing for children (age 2-18 years) living in their households who had never been tested or had tested as HIV-negative more than 6 months ago. Community-based options involved testing in the home by either a trained lay worker with a blood-based rapid diagnostic test (used in facility-based testing), or by the child's caregiver with an oral HIV test. Among consenting individuals, the primary outcome was testing uptake in terms of the proportion of eligible children tested. Secondary outcomes were uptake of the different HIV testing methods, HIV yield (proportion of eligible children who tested positive), and HIV prevalence (proportion of HIV-positive children among those tested). Logistic regression adjusting for within-index clustering was used to investigate index patient and child characteristics associated with testing uptake, and the uptake of community-based versus facility-based testing.
FINDINGS
Overall, 2870 index patients were linked with 6062 eligible children (3115 [51·4%] girls [sex unknown in seven], median age 8 years [IQR 5-13]). Testing was accepted by index patients for 5326 (87·9%) children, and 3638 were tested with a known test outcome, giving an overall testing uptake among 6062 eligible children of 60·0%. 39 children tested positive for HIV, giving an HIV prevalence among the 3638 children of 1·1% and an HIV yield among 6062 eligible children of 0·6%. Uptake was positively associated with female sex in the index patient (adjusted odds ratio [aOR] 1·56 [95% CI 1·38-1·77], p<0·0001) and child (aOR 1·10 [1·03-1·19], p=0·0080), and negatively associated with any financial cost of travel to a clinic (aOR 0·86 [0·83-0·88], p<0·0001), increased child age (6-9 years: aOR 0·99 (0·89-1·09); 10-15 years: aOR 0·91 [0·83-1·00]; and 16-18 years: aOR 0·75 [0·66-0·85]; p=0·0001 vs 2-5 years), and unknown HIV status of the mother (aOR 0·81 [0·68-0·98], p=0·027 vs HIV-positive status). Additionally, children had increased odds of being tested if community-based testing was chosen over facility-based testing at screening (1320 [73·9%] children tested of 1787 vs 2318 [65·5%] of 3539; aOR 1·49 [1·22-1·81], p=0·0001).
INTERPRETATION
The HIV yield of index-linked testing was low compared with blanket testing approaches in similar settings. Index-linked HIV testing can improve testing uptake among children, although strategies that improve testing uptake in older children are needed. Community based testing by lay workers is a feasible strategy that can be used to improve uptake of HTS among children and adolescents.
FUNDING
UK Medical Research Council, UK Department for International Development, Wellcome Trust.

Identifiants

pubmed: 33197393
pii: S2352-3018(20)30267-8
doi: 10.1016/S2352-3018(20)30267-8
pmc: PMC8011056
pii:
doi:

Types de publication

Comparative Study Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e138-e148

Subventions

Organisme : Medical Research Council
ID : MR/P011268/1
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/R010161/1
Pays : United Kingdom
Organisme : Wellcome Trust
ID : 206316/Z/17/Z
Pays : United Kingdom

Commentaires et corrections

Type : CommentIn

Informations de copyright

Copyright © 2021 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license. Published by Elsevier Ltd.. All rights reserved.

Références

BMC Public Health. 2019 Oct 15;19(1):1289
pubmed: 31615461
PLoS Med. 2017 Jul 25;14(7):e1002360
pubmed: 28742829
AIDS. 2016 Mar 13;30(5):779-85
pubmed: 26588175
Lancet Infect Dis. 2014 Jul;14(7):627-39
pubmed: 24406145
PLoS One. 2019 Mar 27;14(3):e0212762
pubmed: 30917167
Curr Opin HIV AIDS. 2018 May;13(3):257-264
pubmed: 29401121
Clin Infect Dis. 2010 Oct 1;51(7):844-51
pubmed: 20804412
PLoS Med. 2015 Sep 08;12(9):e1001873
pubmed: 26348035
PLoS One. 2015 Aug 14;10(8):e0135048
pubmed: 26275059
J Int AIDS Soc. 2015 Oct 14;18:20182
pubmed: 26471265
BMJ Open. 2019 Jul 9;9(7):e029428
pubmed: 31289091
J Acquir Immune Defic Syndr. 2016 Dec 15;73(5):e83-e89
pubmed: 27846074
Trop Med Int Health. 2017 Aug;22(8):1021-1029
pubmed: 28544728
BMC Pediatr. 2018 Sep 25;18(1):309
pubmed: 30253758
N Engl J Med. 2008 Nov 20;359(21):2233-44
pubmed: 19020325
PLoS One. 2015 Aug 06;10(8):e0134571
pubmed: 26248197
AIDS. 2008 Mar 30;22(6):759-66
pubmed: 18356606
Bone. 2019 Aug;125:96-102
pubmed: 31082498
Curr Opin Infect Dis. 2018 Feb;31(1):14-24
pubmed: 29232277
AIDS. 2018 Nov 28;32(18):2739-2748
pubmed: 30289814
J Acquir Immune Defic Syndr. 2019 Dec 1;82(4):368-372
pubmed: 31425318
Trop Med Int Health. 2011 Jul;16(7):828-9
pubmed: 21418449
Lancet HIV. 2015 Apr;2(4):e159-68
pubmed: 25844394
Clin Infect Dis. 2018 Apr 3;66(8):1211-1221
pubmed: 29136117

Auteurs

Chido Dziva Chikwari (C)

Clinical Research Department, London School of Hygiene & Tropical Medicine, London, UK; Biomedical Research and Training Institute, Harare, Zimbabwe. Electronic address: chido.dzivachikwari@lshtm.ac.uk.

Victoria Simms (V)

Medical Research Council Tropical Epidemiology Group, London School of Hygiene & Tropical Medicine, London, UK; Biomedical Research and Training Institute, Harare, Zimbabwe.

Katharina Kranzer (K)

Clinical Research Department, London School of Hygiene & Tropical Medicine, London, UK; Biomedical Research and Training Institute, Harare, Zimbabwe.

Stefanie Dringus (S)

Clinical Research Department, London School of Hygiene & Tropical Medicine, London, UK.

Rudo Chikodzore (R)

Ministry of Health and Child Care, Bulawayo, Zimbabwe.

Edwin Sibanda (E)

Health Services Department, Bulawayo, Zimbabwe.

Karen Webb (K)

Organization for Public Health Interventions and Development, Harare, Zimbabwe.

Barbara Engelsmann (B)

Organization for Public Health Interventions and Development, Harare, Zimbabwe.

Nicol Redzo (N)

Biomedical Research and Training Institute, Harare, Zimbabwe.

Tsitsi Bandason (T)

Biomedical Research and Training Institute, Harare, Zimbabwe.

Hilda Mujuru (H)

Department of Paediatrics, University of Zimbabwe, Harare, Zimbabwe.

Tsitsi Apollo (T)

AIDS and Tuberculosis Unit, Ministry of Health and Child Care, Harare, Zimbabwe.

Getrude Ncube (G)

AIDS and Tuberculosis Unit, Ministry of Health and Child Care, Harare, Zimbabwe.

Karen Hatzold (K)

Population Services International, Harare, Zimbabwe.

Helen A Weiss (HA)

Medical Research Council Tropical Epidemiology Group, London School of Hygiene & Tropical Medicine, London, UK.

Rashida A Ferrand (RA)

Clinical Research Department, London School of Hygiene & Tropical Medicine, London, UK; Biomedical Research and Training Institute, Harare, Zimbabwe.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH